A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Phase 1a is a dose escalation to evaluate the safety and tolerability of NX-2127 in adult patients with relapsed/refractory (R/R) […]
Chronic Lymphocytic Leukemia (CLL)
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Phase 1a is a dose escalation to evaluate the safety and tolerability of NX-5948 in adult patients with relapsed/refractory (R/R)